- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
24Q2 (20) | 7.07 | 0 | 5.68 | 1.64 | 0 | 20.59 | 0.94 | 0 | 1.08 | 0 | 0 | 0 | 23.20 | 23.66 | 14.11 | 13.30 | -5.73 | -4.36 | 0.00 | 0 | 0 | 126 | 0 | 0.0 |
24Q1 (19) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | 0 | 0 | 18.76 | 0.0 | -18.83 | 14.10 | 0.0 | -4.09 | 0.00 | 0 | 0 | 0 | -100.0 | 0 |
23Q4 (18) | 7.09 | 0 | -0.7 | 1.33 | 0 | -19.39 | 1.0 | 0 | -4.76 | 0 | 0 | 0 | 18.76 | -7.72 | -18.83 | 14.10 | 1.46 | -4.09 | 0.00 | 0 | 0 | 126 | 0 | 0.0 |
23Q3 (17) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | 0 | 0 | 20.33 | 0.0 | -0.35 | 13.90 | 0.0 | -3.39 | 0.00 | 0 | 0 | 0 | -100.0 | 0 |
23Q2 (16) | 6.69 | 0 | 21.86 | 1.36 | 0 | 21.43 | 0.93 | 0 | 17.72 | 0 | 0 | 0 | 20.33 | -12.03 | -0.35 | 13.90 | -5.47 | -3.39 | 0.00 | 0 | 0 | 126 | 0 | 0.0 |
23Q1 (15) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | 0 | 0 | 23.11 | 0.0 | 8.74 | 14.71 | 0.0 | -6.09 | 0.00 | 0 | 0 | 0 | -100.0 | 0 |
22Q4 (14) | 7.14 | 0 | 59.73 | 1.65 | 0 | 73.68 | 1.05 | 0 | 50.0 | 0 | 0 | 0 | 23.11 | 13.28 | 8.74 | 14.71 | 2.2 | -6.09 | 0.00 | 0 | 0 | 126 | 0 | 0.0 |
22Q3 (13) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | 0 | 0 | 20.40 | 0.0 | 4.25 | 14.39 | 0.0 | 11.41 | 0.00 | 0 | 0 | 0 | -100.0 | 0 |
22Q2 (12) | 5.49 | 0 | 7.44 | 1.12 | 0 | 12.0 | 0.79 | 0 | 19.7 | 0 | 0 | 0 | 20.40 | -4.01 | 4.25 | 14.39 | -8.11 | 11.41 | 0.00 | 0 | 0 | 126 | 0 | 0.0 |
22Q1 (11) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | 0 | 0 | 21.25 | 0.0 | -8.53 | 15.66 | 0.0 | 18.53 | 0.00 | 0 | 0 | 0 | -100.0 | 0 |
21Q4 (10) | 4.47 | 0 | 1.82 | 0.95 | 0 | -6.86 | 0.7 | 0 | 20.69 | 0 | 0 | 0 | 21.25 | 8.6 | -8.53 | 15.66 | 21.25 | 18.53 | 0.00 | 0 | 0 | 126 | 0 | 0.0 |
21Q3 (9) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | 0 | 0 | 19.57 | 0.0 | -0.32 | 12.92 | 0.0 | 27.01 | 0.00 | 0 | 0 | 0 | -100.0 | 0 |
21Q2 (8) | 5.11 | 0 | -27.82 | 1.0 | 0 | -28.06 | 0.66 | 0 | -8.33 | 0 | 0 | 0 | 19.57 | -15.77 | -0.32 | 12.92 | -2.24 | 27.01 | 0.00 | 0 | 0 | 126 | 0 | 0.0 |
21Q1 (7) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | 0 | 0 | 23.23 | 0.0 | 28.74 | 13.21 | 0.0 | 39.55 | 0.00 | 0 | 0 | 0 | -100.0 | 0 |
20Q4 (6) | 4.39 | 0 | 29.88 | 1.02 | 0 | 67.21 | 0.58 | 0 | 81.25 | 0 | 0 | 0 | 23.23 | 18.35 | 28.74 | 13.21 | 29.92 | 39.55 | 0.00 | 0 | 0 | 126 | 0 | 0.0 |
20Q3 (5) | 0 | -100.0 | -100.0 | 0 | -100.0 | -100.0 | 0 | -100.0 | -100.0 | 0 | 0 | 0 | 19.63 | 0.0 | 26.47 | 10.17 | 0.0 | -9.13 | 0.00 | 0 | 0 | 0 | -100.0 | -100.0 |
20Q2 (4) | 7.08 | 0 | 0.0 | 1.39 | 0 | 0.0 | 0.72 | 0 | 0.0 | 0 | 0 | 0.0 | 19.63 | 8.78 | 0.0 | 10.17 | 7.42 | 0.0 | 0.00 | 0 | 0.0 | 126 | 0 | 0.0 |
20Q1 (3) | 0 | -100.0 | 0.0 | 0 | -100.0 | 0.0 | 0 | -100.0 | 0.0 | 0 | 0 | 0.0 | 18.05 | 0.0 | 0.0 | 9.47 | 0.0 | 0.0 | 0.00 | 0 | 0.0 | 0 | -100.0 | 0.0 |
19Q4 (2) | 3.38 | 22.02 | 0.0 | 0.61 | 41.86 | 0.0 | 0.32 | 3.23 | 0.0 | 0 | 0 | 0.0 | 18.05 | 16.26 | 0.0 | 9.47 | -15.4 | 0.0 | 0.00 | 0 | 0.0 | 126 | 0.0 | 0.0 |
19Q3 (1) | 2.77 | 0.0 | 0.0 | 0.43 | 0.0 | 0.0 | 0.31 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 15.52 | 0.0 | 0.0 | 11.19 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 126 | 0.0 | 0.0 |
營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 13.78 | 9.11 | 2.69 | -2.89 | 1.94 | 5.43 | 0 | 0 | 19.52 | -10.99 | 14.08 | -3.36 | 0.00 | 0 | 126 | 0.0 |
2022 (9) | 12.63 | 31.84 | 2.77 | 42.05 | 1.84 | 35.29 | 0 | 0 | 21.93 | 7.75 | 14.57 | 2.62 | 0.00 | 0 | 126 | 0.0 |
2021 (8) | 9.58 | -16.48 | 1.95 | -19.09 | 1.36 | 3.82 | 0 | 0 | 20.35 | -3.12 | 14.20 | 24.3 | 0.00 | 0 | 126 | 0.0 |
2020 (7) | 11.47 | 4.27 | 2.41 | 28.88 | 1.31 | 13.91 | 0 | 0 | 21.01 | 23.6 | 11.42 | 9.25 | 0.00 | 0 | 126 | 0.0 |
2019 (6) | 11.0 | 21.15 | 1.87 | -2.6 | 1.15 | -6.5 | 0 | 0 | 17.00 | -19.6 | 10.45 | -22.82 | 0.00 | 0 | 126 | 0.0 |
2018 (5) | 9.08 | 6.32 | 1.92 | -27.82 | 1.23 | -6.82 | 0 | 0 | 21.15 | -32.11 | 13.55 | -12.36 | 0.00 | 0 | 126 | 0 |
2017 (4) | 8.54 | -23.48 | 2.66 | 23.15 | 1.32 | -5.04 | 0 | 0 | 31.15 | 60.93 | 15.46 | 24.1 | 0.00 | 0 | 0 | 0 |
2016 (3) | 11.16 | -13.62 | 2.16 | 20.67 | 1.39 | -44.62 | 0 | 0 | 19.35 | 39.7 | 12.46 | -35.89 | 0.00 | 0 | 0 | 0 |
2015 (2) | 12.92 | -36.51 | 1.79 | -28.11 | 2.51 | -1.57 | 0 | 0 | 13.85 | 13.23 | 19.43 | 55.04 | 0.00 | 0 | 0 | 0 |
2014 (1) | 20.35 | 27.75 | 2.49 | 23.88 | 2.55 | 6.25 | 0 | 0 | 12.24 | 0 | 12.53 | 0 | 0.00 | 0 | 0 | 0 |